Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$10.86 USD
+0.63 (6.16%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $10.86 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO8/12/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -1.37 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.36 |
Next Year | -0.36 |
EPS (TTM) | -14.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.26M | 0.24M | 0.99M | 0.96M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.26M | 0.24M | 0.99M | 0.96M |
Low Estimate | 0.26M | 0.24M | 0.99M | 0.96M |
Year ago Sales | 0.70M | 0.37M | 1.83M | 0.99M |
Year over Year Growth Est. | -62.86% | -35.14% | -45.75% | -3.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | -0.07 | -0.36 | -0.36 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.07 | -0.07 | -0.36 | -0.36 |
High Estimate | -0.07 | -0.07 | -0.36 | -0.36 |
Low Estimate | -0.07 | -0.07 | -0.36 | -0.36 |
Year ago EPS | -5.00 | -4.07 | -18.70 | -0.36 |
Year over Year Growth Est. | 98.60% | 98.28% | 98.07% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | -0.07 | -0.36 | -0.36 |
7 Days Ago | -0.07 | -0.07 | -0.34 | -0.34 |
30 Days Ago | -0.07 | -0.07 | -0.34 | -0.34 |
60 Days Ago | NA | NA | -11.80 | NA |
90 Days Ago | NA | NA | -11.80 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.07 | -0.07 | -0.36 | -0.36 |
Zacks Consensus Estimate | -0.07 | -0.07 | -0.36 | -0.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.37 | -4.06 | -4.07 | -5.00 | NA |
Estimate | NA | NA | -4.00 | NA | NA |
Difference | NA | NA | -0.07 | NA | -0.07 |
Surprise | NA | NA | -1.75% | NA | -1.75% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more